Biogen Inc. (BIIB)

300.86
2.00 0.66
NASDAQ : Health Technology
Prev Close 302.86
Open 303.04
Day Low/High 299.71 / 304.68
52 Wk Low/High 215.78 / 374.99
Volume 353.99K
Avg Volume 1.97M
Exchange NASDAQ
Shares Outstanding 163.19M
Market Cap 49.19B
EPS 31.50
P/E Ratio 9.32
Div & Yield N.A. (N.A)
Approach Biogen With Caution

Approach Biogen With Caution

The drug stock has soared sharply higher in recent weeks; how it behaves on a pullback will be key.

Biogen and Ionis See Boost From Clinical Drug Trial

Biogen and Ionis See Boost From Clinical Drug Trial

Shares of Biogen and Ionis Pharmaceuticals were higher Monday after announcing that their treatment for a rare, children's spine disorder had some positive results.

Trending Tickers: MUR, DO, BIIB, VZ

Trending Tickers: MUR, DO, BIIB, VZ

As crude oil falls below $40, stocks tied to oil are reeling.

Cramer: What Are You Thinking? It Should Be Long Term

Cramer: What Are You Thinking? It Should Be Long Term

That may be the best way to get through the notorious month of August.

Midday Report: Biogen Lifts Biotech; U.S. Stocks Break Higher

Midday Report: Biogen Lifts Biotech; U.S. Stocks Break Higher

Stocks break free of range-bound trading by late morning as gains in biotech help to offset losses in energy.

Where Is the Insider Buying?

The market is off its worst levels of the day. Big biotech and biopharma are providing strength today, with Biogen , Gilead Sciences and Mylan all sporting solid gains in a down market. Energy has made a bit of a comeback, but still is down nearly 2...

I'm Bullish on Biotechs

The market continues to trade lower as we late morning, with Tobira Therapeutics serving as the "disaster du jour" in the small-cap biotech space. This stock is trading down some 60% after its midstage compound targeting non-alcoholic steatohepatiti...

Midday Report: Existing Home Sales at Best Since 2007; U.S. Stocks Mixed

Midday Report: Existing Home Sales at Best Since 2007; U.S. Stocks Mixed

Quarterly reports continued to come in at breakneck speed with some of the key highlights including American Express, eBay, General Motors, Southwest Airlines, and Biogen.

Biogen Shares Climb on Earnings Beat, CEO Departure

Biogen Shares Climb on Earnings Beat, CEO Departure

Biogen shares could be on a turnaround trajectory after a year of disappointments.

Morning Movers: GM, JOY, RLYP, BIIB

Morning Movers: GM, JOY, RLYP, BIIB

General Motors crushed Wall Street earnings estimates before the opening bell.

What to Watch This Week: Bank of America, Goldman Sachs, Netflix and Yahoo! Report Earnings

What to Watch This Week: Bank of America, Goldman Sachs, Netflix and Yahoo! Report Earnings

For the week of July 18, the earnings parade continues, with dozens of major companies reporting financial results.

Here's Why Action Alerts PLUS Exited Biogen Today

Here's Why Action Alerts PLUS Exited Biogen Today

The charitable trust sold out of its position in Biogen while also trimming its holdings in Target.

WhiteWave Rides Another Downgrade

WhiteWave Rides Another Downgrade

The organic food producer was downgraded to 'Hold' by Jefferies.

Beaten-Down Biogen May Be Biotech Bargain

Beaten-Down Biogen May Be Biotech Bargain

Any turn in the fundamentals or sentiment easily can send these shares trading much higher from here.

Biogen: Quality at a Discount

Biogen: Quality at a Discount

Biotechs now offer some great valuations, and BIIB is prime example.

Portfolio Roundup: AAPL, BIIB, COST

Portfolio Roundup: AAPL, BIIB, COST

Action Alerts PLUS holdings Apple, Biogen and Costco make moves in the market with Brexit concerns, drug prospects and overall vulnerability. 

Trader's Daily Notebook: If There's a Bounce, It Won't Last Long

Trader's Daily Notebook: If There's a Bounce, It Won't Last Long

But above all, know your time frame.

Think of This Stock as Buy-ogen

Think of This Stock as Buy-ogen

The objective message of the market on Biogen is that selling actions are no longer indicated, and buying actions are.

Cramer: Why Can't We Get Together on Mergers?

Cramer: Why Can't We Get Together on Mergers?

The federal government has turned violently against these deals.

Looking for Relief From Biotech Pain

Looking for Relief From Biotech Pain

A lost leader in Celgene and a Perrigo rumor have put a scare in the charts.

Cramer: Here's What's Really Behind This Hatred for Biotechs

Cramer: Here's What's Really Behind This Hatred for Biotechs

This is the group that is the most dangerous politically.

Citigroup Downgrades Shares of Biogen

Citigroup Downgrades Shares of Biogen

Shares of Biogen traded higher on Wednesday despite a ratings downgrade by Citigroup.

Trending tickers: PAY, PLAY, SKUL, BIIB

U.S. indices are in the green Wednesday as commodities gain. 

Biogen downgraded at Citi

Rev's Forum: Don't Be Seduced by the Market's Dark Side

Too many turn bearish too quickly just because they can't find any entry points.

Trader's Daily Notebook: Gusher for Oil Stocks

Trader's Daily Notebook: Gusher for Oil Stocks

Big move for biotechs isn't pleasant.

Closing Bell: Icahn Ups Hertz Stake; S&P 500 Rises as Oil Tops $50

Closing Bell: Icahn Ups Hertz Stake; S&P 500 Rises as Oil Tops $50

The S&P 500 clinched a new closing high for 2016 as crude closed above $50 a barrel on Tuesday.

Here’s Why Shares of Biogen and Alexion Tanked On Tuesday

Here’s Why Shares of Biogen and Alexion Tanked On Tuesday

Shares of Biogen and Alexion Pharmaceuticals took a hit Tuesday after their promising new products failed clinical trials.

Trending Tickers: Z, VRX, BIIB, ALXN

U.S. indices are up as oil continues its climb past $50 a barrel.